RT Journal Article SR Electronic T1 Consensus Recommendations on the Use of 18F-FDG PET/CT in Lung Disease JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 1701 OP 1707 DO 10.2967/jnumed.120.244780 VO 61 IS 12 A1 Delphine L. Chen A1 Safia Ballout A1 Laigao Chen A1 Joseph Cheriyan A1 Gourab Choudhury A1 Ana M. Denis-Bacelar A1 Elise Emond A1 Kjell Erlandsson A1 Marie Fisk A1 Francesco Fraioli A1 Ashley M. Groves A1 Roger N. Gunn A1 Jun Hatazawa A1 Beverley F. Holman A1 Brian F. Hutton A1 Hidehiro Iida A1 Sarah Lee A1 William MacNee A1 Keiko Matsunaga A1 Divya Mohan A1 David Parr A1 Alaleh Rashidnasab A1 Gaia Rizzo A1 Deepak Subramanian A1 Ruth Tal-Singer A1 Kris Thielemans A1 Nicola Tregay A1 Edwin J.R. van Beek A1 Laurence Vass A1 Marcos F. Vidal Melo A1 Jeremy W. Wellen A1 Ian Wilkinson A1 Frederick J. Wilson A1 Tilo Winkler YR 2020 UL http://jnm.snmjournals.org/content/61/12/1701.abstract AB PET with 18F-FDG has been increasingly applied, predominantly in the research setting, to study drug effects and pulmonary biology and to monitor disease progression and treatment outcomes in lung diseases that interfere with gas exchange through alterations of the pulmonary parenchyma, airways, or vasculature. To date, however, there are no widely accepted standard acquisition protocols or imaging data analysis methods for pulmonary 18F-FDG PET/CT in these diseases, resulting in disparate approaches. Hence, comparison of data across the literature is challenging. To help harmonize the acquisition and analysis and promote reproducibility, we collated details of acquisition protocols and analysis methods from 7 PET centers. From this information and our discussions, we reached the consensus recommendations given here on patient preparation, choice of dynamic versus static imaging, image reconstruction, and image analysis reporting.